Cerus Pre-Tax Income 2010-2024 | CERS
Cerus pre-tax income from 2010 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
| Cerus Annual Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2024 | $-21 |
| 2023 | $-37 |
| 2022 | $-42 |
| 2021 | $-54 |
| 2020 | $-60 |
| 2019 | $-71 |
| 2018 | $-57 |
| 2017 | $-57 |
| 2016 | $-63 |
| 2015 | $-60 |
| 2014 | $-39 |
| 2013 | $-43 |
| 2012 | $-16 |
| 2011 | $-17 |
| 2010 | $-17 |
| 2009 | $-24 |
| Cerus Quarterly Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-2 |
| 2024-09-30 | $-3 |
| 2024-06-30 | $-6 |
| 2024-03-31 | $-10 |
| 2023-12-31 | $-1 |
| 2023-09-30 | $-7 |
| 2023-06-30 | $-13 |
| 2023-03-31 | $-16 |
| 2022-12-31 | $-13 |
| 2022-09-30 | $-8 |
| 2022-06-30 | $-8 |
| 2022-03-31 | $-12 |
| 2021-12-31 | $-9 |
| 2021-09-30 | $-12 |
| 2021-06-30 | $-15 |
| 2021-03-31 | $-17 |
| 2020-12-31 | $-14 |
| 2020-09-30 | $-14 |
| 2020-06-30 | $-15 |
| 2020-03-31 | $-16 |
| 2019-12-31 | $-17 |
| 2019-09-30 | $-18 |
| 2019-06-30 | $-18 |
| 2019-03-31 | $-19 |
| 2018-12-31 | $-16 |
| 2018-09-30 | $-14 |
| 2018-06-30 | $-13 |
| 2018-03-31 | $-14 |
| 2017-12-31 | $-12 |
| 2017-09-30 | $-13 |
| 2017-06-30 | $-13 |
| 2017-03-31 | $-19 |
| 2016-12-31 | $-15 |
| 2016-09-30 | $-15 |
| 2016-06-30 | $-17 |
| 2016-03-31 | $-16 |
| 2015-12-31 | $-17 |
| 2015-09-30 | $-16 |
| 2015-06-30 | $-18 |
| 2015-03-31 | $-9 |
| 2014-12-31 | $-20 |
| 2014-09-30 | $-11 |
| 2014-06-30 | $-8 |
| 2014-03-31 | $0 |
| 2013-12-31 | $-6 |
| 2013-09-30 | $-20 |
| 2013-06-30 | $-7 |
| 2013-03-31 | $-10 |
| 2012-12-31 | $-2 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-2 |
| 2012-03-31 | $-9 |
| 2011-12-31 | $-8 |
| 2011-09-30 | $2 |
| 2011-06-30 | $-6 |
| 2011-03-31 | $-5 |
| 2010-12-31 | $-2 |
| 2010-09-30 | $-4 |
| 2010-06-30 | $-6 |
| 2010-03-31 | $-5 |
| 2009-12-31 | $-5 |
| 2009-09-30 | $-6 |
| 2009-06-30 | $-6 |
| 2009-03-31 | $-7 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.239B | $0.180B |
| Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.503B | 27.84 |
| Boston Scientific (BSX) | United States | $154.040B | 38.56 |
| Stryker (SYK) | United States | $144.095B | 30.13 |
| EssilorLuxottica (ESLOY) | France | $132.622B | 0.00 |
| Medtronic (MDT) | Ireland | $105.579B | 15.42 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.866B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.124B | 27.36 |
| ResMed (RMD) | United States | $35.477B | 26.65 |
| GE HealthCare Technologies (GEHC) | United States | $30.720B | 14.59 |
| Agilent Technologies (A) | United States | $30.004B | 19.82 |
| Terumo (TRUMY) | Japan | $29.197B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.643B | 16.28 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.255B | 11.72 |
| Insulet (PODD) | United States | $18.215B | 77.74 |
| Baxter (BAX) | United States | $15.352B | 11.47 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.456B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.970B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.179B | 17.65 |
| Bio-Rad Laboratories (BIO) | United States | $6.487B | 21.93 |
| Prestige Consumer Healthcare (PBH) | United States | $4.014B | 19.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.368B | 9.64 |
| ICU Medical (ICUI) | United States | $3.306B | 28.16 |
| Haemonetics (HAE) | United States | $3.194B | 15.03 |
| Envista Holdings (NVST) | United States | $2.778B | 23.08 |
| GN Store Nord (GNNDY) | Denmark | $2.069B | 17.14 |
| LeMaitre Vascular (LMAT) | United States | $1.855B | 41.46 |
| QuidelOrtho (QDEL) | United States | $1.750B | 14.65 |
| AtriCure (ATRC) | United States | $1.478B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.281B | 20.17 |
| AdaptHealth (AHCO) | United States | $1.194B | 12.12 |
| Neogen (NEOG) | United States | $1.192B | 15.25 |
| Kestra Medical Technologies (KMTS) | United States | $1.139B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.043B | 0.00 |
| InMode (INMD) | Israel | $0.995B | 9.11 |
| Phibro Animal Health (PAHC) | United States | $0.771B | 11.83 |
| Evolus (EOLS) | United States | $0.749B | 0.00 |
| Owens & Minor (OMI) | United States | $0.596B | 5.07 |
| Curaleaf Holdings (CURLF) | Canada | $0.579B | 0.00 |
| CeriBell (CBLL) | United States | $0.568B | 0.00 |
| Valneva SE (VALN) | France | $0.542B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.518B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.424B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.420B | 0.00 |
| Surmodics (SRDX) | United States | $0.391B | 0.00 |
| Omeros (OMER) | United States | $0.370B | 0.00 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.340B | 14.75 |
| Capricor Therapeutics (CAPR) | United States | $0.333B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.302B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.292B | 26.43 |
| Sanara MedTech (SMTI) | United States | $0.283B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.262B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.259B | 46.10 |
| ZimVie (ZIMV) | United States | $0.245B | 14.65 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.217B | 0.00 |
| Quanterix (QTRX) | United States | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Biote (BTMD) | United States | $0.184B | 4.21 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.16 |
| TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
| Brainsway (BWAY) | Israel | $0.162B | 50.65 |
| Organigram Global (OGI) | Canada | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.146B | 17.99 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.117B | 0.00 |
| Exagen (XGN) | United States | $0.116B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.091B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.086B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.58 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.061B | 0.00 |
| United Health Products (UEEC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 55.50 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 11.14 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |